Return
Company Page
SonoMind
SonoMind is a French deeptech medical device company developing a non-invasive, personalized ultrasound-based brain stimulation system to treat drug-resistant depression and other neuropsychiatric disorders. Its technology uses low-intensity focused ultrasound delivered through a patient-specific 3D-printed acoustic lens to precisely target deep brain structures without surgery or implants, with early clinical results showing over 60% reduction in depression severity after five days of treatment.
Company Founded in 2024
Healthtech & Biotech